Invention Grant
- Patent Title: Therapeutics for ocular immunoinflammatory diseases
-
Application No.: US16068300Application Date: 2017-01-06
-
Publication No.: US11306140B2Publication Date: 2022-04-19
- Inventor: Reza Dana , Sunil Chauhan , Yihe Chen
- Applicant: The Schepens Eye Research Institute, Inc.
- Applicant Address: US MA Boston
- Assignee: The Schepens Eye Research Institute, Inc.
- Current Assignee: The Schepens Eye Research Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ingrid A. Beattie
- International Application: PCT/US2017/012547 WO 20170106
- International Announcement: WO2017/120479 WO 20170713
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61P27/04 ; A61K39/00 ; A61L27/54 ; A61K9/00
Abstract:
Methods and compositions for reducing the activity or number of memory Th17 cells in ocular tissue, and for treatment and/or prevention of ocular immunoinflammatory diseases are described.
Public/Granted literature
- US20190008765A1 THERAPEUTICS FOR OCULAR IMMUNOINFLAMMATORY DISEASES Public/Granted day:2019-01-10
Information query
